Imatinib, a tyrosine kinase inhibitor of PDGFR (PDGF receptor) has been shown to inhibit the growth of a number of human neuroblastoma cell lines in vitro and xenograft in vivo [53]. This evidence concerns the gene PDGFRB and neuroblastoma.